Standard
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression. / Mocroft, Amanda; Bannister, Wendy P; Kirk, Ole; Kowalska, Justyna D; Reiss, Peter; D'Arminio-Monforte, Antonella; Gatell, Jose; Fisher, Martin; Trocha, Hanna; Rakhmanova, Aza; Lundgren, Jens D; EuroSIDA Study in EuroCOORD.
I:
Antiviral Therapy, Bind 17, Nr. 7, 2012, s. 1291-300.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Mocroft, A, Bannister, WP
, Kirk, O, Kowalska, JD, Reiss, P, D'Arminio-Monforte, A, Gatell, J, Fisher, M, Trocha, H, Rakhmanova, A
, Lundgren, JD & EuroSIDA Study in EuroCOORD 2012, '
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression',
Antiviral Therapy, bind 17, nr. 7, s. 1291-300.
https://doi.org/10.3851/IMP2407APA
Mocroft, A., Bannister, W. P.
, Kirk, O., Kowalska, J. D., Reiss, P., D'Arminio-Monforte, A., Gatell, J., Fisher, M., Trocha, H., Rakhmanova, A.
, Lundgren, J. D., & EuroSIDA Study in EuroCOORD (2012).
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.
Antiviral Therapy,
17(7), 1291-300.
https://doi.org/10.3851/IMP2407Vancouver
Mocroft A, Bannister WP
, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A o.a.
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.
Antiviral Therapy. 2012;17(7):1291-300.
https://doi.org/10.3851/IMP2407Author
Mocroft, Amanda ; Bannister, Wendy P ; Kirk, Ole ; Kowalska, Justyna D ; Reiss, Peter ; D'Arminio-Monforte, Antonella ; Gatell, Jose ; Fisher, Martin ; Trocha, Hanna ; Rakhmanova, Aza ; Lundgren, Jens D ; EuroSIDA Study in EuroCOORD. / The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression. I: Antiviral Therapy. 2012 ; Bind 17, Nr. 7. s. 1291-300.
Bibtex
@article{35a854d6cc344508a5ff463d0ce5572d,
title = "The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression",
abstract = "The aim of this study was to determine whether there is a protective effect of combination antiretroviral therapy (cART) on the development of clinical events in patients with ongoing severe immunosuppression.",
keywords = "Acquired Immunodeficiency Syndrome, Adult, CD4 Lymphocyte Count, Drug Evaluation, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Protease Inhibitors, HIV-1, Humans, Immunocompromised Host, Incidence, Male, Middle Aged, Poisson Distribution, Prospective Studies, Reverse Transcriptase Inhibitors, Risk Factors, Viral Load, Viremia",
author = "Amanda Mocroft and Bannister, {Wendy P} and Ole Kirk and Kowalska, {Justyna D} and Peter Reiss and Antonella D'Arminio-Monforte and Jose Gatell and Martin Fisher and Hanna Trocha and Aza Rakhmanova and Lundgren, {Jens D} and {EuroSIDA Study in EuroCOORD}",
year = "2012",
doi = "10.3851/IMP2407",
language = "English",
volume = "17",
pages = "1291--300",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press",
number = "7",
}
RIS
TY - JOUR
T1 - The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression
AU - Mocroft, Amanda
AU - Bannister, Wendy P
AU - Kirk, Ole
AU - Kowalska, Justyna D
AU - Reiss, Peter
AU - D'Arminio-Monforte, Antonella
AU - Gatell, Jose
AU - Fisher, Martin
AU - Trocha, Hanna
AU - Rakhmanova, Aza
AU - Lundgren, Jens D
AU - EuroSIDA Study in EuroCOORD
PY - 2012
Y1 - 2012
N2 - The aim of this study was to determine whether there is a protective effect of combination antiretroviral therapy (cART) on the development of clinical events in patients with ongoing severe immunosuppression.
AB - The aim of this study was to determine whether there is a protective effect of combination antiretroviral therapy (cART) on the development of clinical events in patients with ongoing severe immunosuppression.
KW - Acquired Immunodeficiency Syndrome
KW - Adult
KW - CD4 Lymphocyte Count
KW - Drug Evaluation
KW - Drug Therapy, Combination
KW - Female
KW - Follow-Up Studies
KW - HIV Protease Inhibitors
KW - HIV-1
KW - Humans
KW - Immunocompromised Host
KW - Incidence
KW - Male
KW - Middle Aged
KW - Poisson Distribution
KW - Prospective Studies
KW - Reverse Transcriptase Inhibitors
KW - Risk Factors
KW - Viral Load
KW - Viremia
U2 - 10.3851/IMP2407
DO - 10.3851/IMP2407
M3 - Journal article
C2 - 23013779
VL - 17
SP - 1291
EP - 1300
JO - Antiviral Therapy
JF - Antiviral Therapy
SN - 1359-6535
IS - 7
ER -
